Constellation Pharmaceuticals Garners $15,000,000 Series B Funding

  • Feed Type
  • Date
    6/6/2011
  • Company Name
    Constellation Pharmaceuticals
  • Mailing Address
    148 Sidney Street Cambridge, MA 02139
  • Company Description
    Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
  • Website
    http://www.constellationpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from this round of financing will allow the company to continue to advance product candidates in its portfolio toward clinical development.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    The Column Group
  • Venture Investor
    Venrock
  • Venture Investor
    SR One

By posting a comment, you agree to our terms and conditions.